Israel · Delayed Price · Currency is ILS · Price in ILA BrainsWay Statistics
Total Valuation
BrainsWay has a market cap or net worth of ILS 1.65 billion. The enterprise value is 1.48 billion.
| Market Cap | 1.65B |
| Enterprise Value | 1.48B |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BrainsWay has 40.21 million shares outstanding. The number of shares has increased by 2.01% in one year.
| Current Share Class | 40.21M |
| Shares Outstanding | 40.21M |
| Shares Change (YoY) | +2.01% |
| Shares Change (QoQ) | +1.43% |
| Owned by Insiders (%) | 13.50% |
| Owned by Institutions (%) | 26.57% |
| Float | 24.14M |
Valuation Ratios
The trailing PE ratio is 57.60 and the forward PE ratio is 37.40.
| PE Ratio | 57.60 |
| Forward PE | 37.40 |
| PS Ratio | 9.11 |
| PB Ratio | 6.98 |
| P/TBV Ratio | 6.98 |
| P/FCF Ratio | 95.55 |
| P/OCF Ratio | 73.03 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 53.95, with an EV/FCF ratio of 86.04.
| EV / Earnings | 52.73 |
| EV / Sales | 8.20 |
| EV / EBITDA | 53.95 |
| EV / EBIT | 65.81 |
| EV / FCF | 86.04 |
Financial Position
The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.09.
| Current Ratio | 3.59 |
| Quick Ratio | 3.05 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.77 |
| Debt / FCF | 1.23 |
| Interest Coverage | 4.87 |
Financial Efficiency
Return on equity (ROE) is 12.82% and return on invested capital (ROIC) is 30.70%.
| Return on Equity (ROE) | 12.82% |
| Return on Assets (ROA) | 4.05% |
| Return on Invested Capital (ROIC) | 30.70% |
| Return on Capital Employed (ROCE) | 7.62% |
| Weighted Average Cost of Capital (WACC) | 4.90% |
| Revenue Per Employee | 1.40M |
| Profits Per Employee | 218,029 |
| Employee Count | 129 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.60 |
Taxes
In the past 12 months, BrainsWay has paid 703,068 in taxes.
| Income Tax | 703,068 |
| Effective Tax Rate | 2.44% |
Stock Price Statistics
The stock price has increased by +54.62% in the last 52 weeks. The beta is 0.08, so BrainsWay's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | +54.62% |
| 50-Day Moving Average | 4,525.52 |
| 200-Day Moving Average | 4,092.29 |
| Relative Strength Index (RSI) | 39.49 |
| Average Volume (20 Days) | 68,319 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BrainsWay had revenue of ILS 180.82 million and earned 28.13 million in profits. Earnings per share was 0.71.
| Revenue | 180.82M |
| Gross Profit | 136.20M |
| Operating Income | 22.54M |
| Pretax Income | 28.83M |
| Net Income | 28.13M |
| EBITDA | 25.27M |
| EBIT | 22.54M |
| Earnings Per Share (EPS) | 0.71 |
Balance Sheet
The company has 185.03 million in cash and 21.25 million in debt, with a net cash position of 163.78 million or 4.07 per share.
| Cash & Cash Equivalents | 185.03M |
| Total Debt | 21.25M |
| Net Cash | 163.78M |
| Net Cash Per Share | 4.07 |
| Equity (Book Value) | 235.91M |
| Book Value Per Share | 6.09 |
| Working Capital | 175.03M |
Cash Flow
In the last 12 months, operating cash flow was 22.55 million and capital expenditures -5.31 million, giving a free cash flow of 17.24 million.
| Operating Cash Flow | 22.55M |
| Capital Expenditures | -5.31M |
| Depreciation & Amortization | 2.78M |
| Net Borrowing | -2.37M |
| Free Cash Flow | 17.24M |
| FCF Per Share | 0.43 |
Margins
Gross margin is 75.32%, with operating and profit margins of 12.46% and 15.55%.
| Gross Margin | 75.32% |
| Operating Margin | 12.46% |
| Pretax Margin | 15.94% |
| Profit Margin | 15.55% |
| EBITDA Margin | 13.98% |
| EBIT Margin | 12.46% |
| FCF Margin | 9.36% |
Dividends & Yields
BrainsWay does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.01% |
| Shareholder Yield | -2.01% |
| Earnings Yield | 1.71% |
| FCF Yield | 1.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 22, 2011. It was a reverse split with a ratio of 0.25.
| Last Split Date | May 22, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
BrainsWay has an Altman Z-Score of 6.15 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.15 |
| Piotroski F-Score | 5 |